CVS Ebit Per Revenue from 2010 to 2024

CVS Stock  USD 44.04  2.56  5.49%   
CVS Health Ebit Per Revenue yearly trend continues to be comparatively stable with very little volatility. Ebit Per Revenue is likely to outpace its year average in 2024. From the period from 2010 to 2024, CVS Health Ebit Per Revenue quarterly data regression had r-value of (0.52) and coefficient of variation of  27.16. View All Fundamentals
 
Ebit Per Revenue  
First Reported
2010-12-31
Previous Quarter
0.0384123
Current Value
0.0641
Quarterly Volatility
0.01395371
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CVS Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CVS Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.6 B, Interest Expense of 2.8 B or Selling General Administrative of 40.3 B, as well as many indicators such as Price To Sales Ratio of 0.27, Dividend Yield of 0.0244 or PTB Ratio of 2.61. CVS financial statements analysis is a perfect complement when working with CVS Health Valuation or Volatility modules.
  
Check out the analysis of CVS Health Correlation against competitors.

Latest CVS Health's Ebit Per Revenue Growth Pattern

Below is the plot of the Ebit Per Revenue of CVS Health Corp over the last few years. It is CVS Health's Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CVS Health's overall financial position and show how it may be relating to other accounts over time.
Ebit Per Revenue10 Years Trend
Slightly volatile
   Ebit Per Revenue   
       Timeline  

CVS Ebit Per Revenue Regression Statistics

Arithmetic Mean0.05
Geometric Mean0.05
Coefficient Of Variation27.16
Mean Deviation0.01
Median0.06
Standard Deviation0.01
Sample Variance0.0002
Range0.0434
R-Value(0.52)
Mean Square Error0.0002
R-Squared0.27
Significance0.04
Slope(0)
Total Sum of Squares0

CVS Ebit Per Revenue History

2024 0.0641
2023 0.0384
2022 0.0247
2021 0.0456
2020 0.0518
2019 0.0467
2018 0.0207

About CVS Health Financial Statements

CVS Health shareholders use historical fundamental indicators, such as Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Although CVS Health investors may analyze each financial statement separately, they are all interrelated. The changes in CVS Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on CVS Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Ebit Per Revenue 0.04  0.06 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for CVS Stock Analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.